JOURNAL BROWSE
Search
Advanced SearchSearch Tips
The Effect of Rutin on Antioxidant and Anti-inflammation in Streptozotocin-induced Diabetic Rats
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Applied Microscopy
  • Volume 43, Issue 2,  2013, pp.54-64
  • Publisher : Korean Society of Electron Microscopy
  • DOI : 10.9729/AM.2013.43.2.54
 Title & Authors
The Effect of Rutin on Antioxidant and Anti-inflammation in Streptozotocin-induced Diabetic Rats
Lee, Yoon Jeong; Jeune, Kyung Hee;
  PDF(new window)
 Abstract
The study examined the antioxidant activities and anti-inflammatory effects of rutin from the streptozotocin (STZ)-induced diabetic rats. Results revealed that the levels of plasma glucose and serum glucose were remarkably higher in the STZ-treated group compared to other groups and were significantly reduced in the STZ+rutin treated group compared to the STZ-treated group. In terms of weight, it significantly increased in all experimental groups during the experiment period except for STZ-induced diabetic group. The weight of the STZ-treated group was remarkably reduced compared to other groups. Regarding the weight of each body organ, the STZ-treated group showed higher organ weight compared to the other groups while STZ+rutin-treated group showed significantly reduced kidney and liver weights compared to those of STZ-treated group. In the pancreas tissue of the STZ-treated group, -cell destruction and vacuolization were observed. Inflammation in the heart, liver, kidney, and retina tissues were also vividly recorded. In the STZ+rutin administered group, the heart and retina tissues were shown to be preserved normally while the liver and kidney tissues showed reduced histopathology in general compared to the STZ-treated group. Conclusionally, the rutin has the effect on the antioxidant activities and anti-inflammation in the STZ-induced diabetic rats.
 Keywords
Rutin;Diabetic rats;Streptozocin;Antioxidant;Anti-inflammation;
 Language
English
 Cited by
 References
1.
Ahmed I, Adeghate E, Sharma A K, Pallot D J, and Singh J (1998) Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res. Clin. Pract. 40, 145-151. crossref(new window)

2.
Aleksandrov P N, Speranskaia T V, Bobkov Iu G, Zagorevskii V A, and Zykov D A (1986) Effect of rutin and esculamine on models of aseptic inflammation. Farmakol. Toksikol. 49, 84-86.

3.
Aronson D, Bartha P, Zinder O, Kerner A, Markiewicz W, Avizohar O, Brook G J, and Levy Y (2004) Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int. J. Obes. Relat. Metab. Disord. 28, 674-679. crossref(new window)

4.
Baynes J W (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412. crossref(new window)

5.
Bear W L and Teel R W (2000) Effects of citrus flavonoids on the mutagenicity of heterocyclic amines and on cytochrome P450 1A2 activity. Anticancer Res. 20, 3609-3614.

6.
Calles-Escandon J and Cipolla M (2001) Diabetes and endothelial dysfunction: a clinical perspective. Endocr. Rev. 22, 36-52. crossref(new window)

7.
Chen S, Gong J, Liu F, and Mohammed U (2000) Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 100, 471-480. crossref(new window)

8.
Coppey L J, Gellett J S, Davidson E P, Dunlap J A, Lund D D, and Yorek M A (2001) Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50, 1927-1937. crossref(new window)

9.
Craig W J (1999) Health-promoting properties of common herbs. Am. J. Clin. Nutr. 70, 491S-499S.

10.
Cuzzocrea S, Riley D P, Caputi A P, and Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53, 135-159.

11.
Dai S, Thompson K H, and McNeill J H (1994) One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate. Pharmacol. Toxicol. 74, 101-109. crossref(new window)

12.
Dandona P, Aljada A, Chaudhuri A, and Bandyopadhyay A (2003) The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J. Clin. Endocrinol. Metab. 88, 2422-2429. crossref(new window)

13.
Deschner E E, Ruperto J, Wong G, and Newmark H L (1991) Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 12, 1193-1196. crossref(new window)

14.
Di Carlo G, Autore G, Izzo A A, Maiolino P, Mascolo N, Viola P, Diurno M V, and Capasso F (1993) Inhibition of intestinal motility and secretion by flavonoids in mice and rats: structure-activity relationships. J. Pharm. Pharmacol. 45, 1054-1059. crossref(new window)

15.
Doi K, Sawada F, Toda G, Yamachika S, Seto S, Urata Y, Ihara Y, Sakata N, Taniguchi N, Kondo T, and Yano K (2001) Alteration of antioxidants during the progression of heart disease in streptozotocin-induced diabetic rats. Free Radic. Res. 34, 251-261. crossref(new window)

16.
Elliott A J, Scheiber S A, Thomas C, and Pardini R S (1992) Inhibition of glutathione reductase by flavonoids. A structure-activity study. Biochem. Pharmacol. 44, 1603-1608. crossref(new window)

17.
Evelson P, Susemihl C, Villarreal I, Llesuy S, Rodriguez R, Peredo H, Lemberg A, Perazzo J, and Filinger E (2005) Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats. Ann. Hepatol. 4, 115-120.

18.
Ferrali M, Signorini C, Caciotti B, Sugherini L, Ciccoli L, Giachetti D, and Comporti M (1997) Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity. FEBS Lett. 416, 123-129. crossref(new window)

19.
Fletcher E L, Phipps J A, Ward M M, Puthussery T, and Wilkinson-Berka J L (2007) Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr. Pharm. 26, 2699-2712.

20.
Furuse M, Kimura C, Mabayo R T, Takahashi H, and Okumura J (1993) Dietary sorbose prevents and improves hyperglycemia in genetically diabetic mice. J. Nutr. 123, 59-65.

21.
Gallaher D D, Csallany A S, Shoeman D W, and Olson J M (1993) Diabetes increases excretion of urinary malonaldehyde conjugates in rats. Lipids 28, 663-666. crossref(new window)

22.
Gao Z, Xu H, and Huang K (2002) Effects of rutin supplementation on antioxidant status and iron, copper, and zinc contents in mouse liver and brain. Biol. Trace. Elem. Res. 88, 271-279. crossref(new window)

23.
Gomes M B and Nogueira V G (2004) Acute-phase proteins and microalbuminuria among patients with type 2 diabetes. Diabetes Res. Clin. Pract. 66, 31-39. crossref(new window)

24.
Grey N J, Karl I, and Kipnis D M (1975) Physiologic mechanisms in the development of starvation ketosis in man. Diabetes 24, 10-16. crossref(new window)

25.
Guha M, Bai W, Nadler J L, and Natarajan R (2000) Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and-independent pathways. J. Biol. Chem. 275, 17728-17739. crossref(new window)

26.
Huang W Y, Zhang H C, Liu W X, and Li C Y (2012) Survey of antioxidant capacity and phenolic composition of blueberry, blackberry, and strawberry in Nanjing. J. Zhejiang Univ. Sci. B 13, 94-102. crossref(new window)

27.
Izuora K E, Chase H P, Jackson W E, Coll J R, Osberg I M, Gottlieb P A, Rewers M J, and Garg S K (2005) Inflammatory markers and diabetic retinopathy in type 1 diabetes. Diabetes Care 28, 714-715. crossref(new window)

28.
Janbaz K H, Saeed S A, and Gilani A H (2002) Protective effect of rutin on paracetamol-and CCl4-induced hepatotoxicity in rodents. Fitoterapia 73, 557-563. crossref(new window)

29.
Kamalakkannan N and Prince P S (2006) Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocininduced diabetic wistar rats. Basic Clin. Pharmacol. Toxicol. 98, 97-103. crossref(new window)

30.
Kang J, Dai X S, Yu T B, Wen B, and Yang Z W (2005) Glycogen accumulation in renal tubules, a key morphological change in the diabetic rat kidney. Acta. Diabetol. 42, 110-116. crossref(new window)

31.
Korkina L G and Afanas'ev I B (1997) Antioxidant and chelating properties of flavonoids. Adv. Pharmacol. 38, 151-163.

32.
Kozlov A B, Ostrachovitch E A, and Afanas'ev I B (1994) Mechanism of inhibitory effects of chelating drugs on lipid peroxidation in rat brain homogenates. Biochem. Pharmacol. 47, 795-799.

33.
Kreft S, Knapp M, and Kreft I (1999) Extraction of rutin from buckwheat (Fagopyrum esculentumMoench) seeds and determination by capillary electrophoresis. J. Agric. Food Chem. 47, 4649-4652. crossref(new window)

34.
Lin Y, Rajala M W, Berger J P, Moller D E, Barzilai N, and Scherer P E (2001) Hyperglycemia-induced production of acute phase reactants in adipose tissue. J. Biol. Chem. 276, 42077-42083. crossref(new window)

35.
Nagasawa T, Tabata N, Ito Y, Aiba Y, Nishizawa N, and Kitts D D (2003a) Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats. Mol. Cell Biochem. 252, 141-147. crossref(new window)

36.
Nagasawa T, Tabata N, Ito Y, Nishizawa N, Aiba Y, and Kitts D D (2003b) Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative. Mol. Cell Biochem. 249, 3-10. crossref(new window)

37.
Potter J D (1997) Cancer prevention: epidemiology and experiment. Cancer Lett. 114, 7-9. crossref(new window)

38.
Pozin V M, Skuratovskaia S G, and Pocheptsova G A (1996) Changes in the vascular wall and ischemic damages to the myocardium in reversible episodes of heart muscle ischemia. Fiziol. Zh. 42, 10-16.

39.
Rayfield E J and Ishimura K (1987) Environmental factors and insulindependent diabetes mellitus. Diabetes Metab. Rev. 3, 925-957. crossref(new window)

40.
Rice-Evans C and Packer L (1998) In Flavonoids in Health and Diseases (Marcel Decker Inc., New York).

41.
Simpson R W, Shaw J E, and Zimmet P Z (2003) The prevention of type2diabetes-lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Res. Clin. Pract. 59, 165-180. crossref(new window)

42.
Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50, 537-546.

43.
Tracy R P (2003) Inflammation, the metabolic syndrome and cardiovascular risk. Int. J. Clin. Pract. Suppl. 134, 10-17.

44.
West K M, Ahuja M M, Bennett P H, Czyzyk A, De Acosta O M, Fuller J H, Grab B, Grabauskas V, Jarrett R J, and Kosaka K (1983) The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 6, 361-369. crossref(new window)

45.
Widlansky M E, Gokce N, Keaney J F Jr, and Vita J A (2003) The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol. 42, 1149-1160. crossref(new window)

46.
World Health Organization/International Diabetes Federation (1999) The Economics of Diabetes and Diabetes Care-A Report of the Diabetes Health Economics Study Group. World Health Organization/ International Diabetes Federation WHO, Geneva.

47.
Zhou R, Tardivel A, Thorens B, Choi I, and Tschopp J (2010) Thioredoxininteracting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136-140. crossref(new window)